Citadel Advisors - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 99 filers reported holding HARVARD BIOSCIENCE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$57,147
-39.4%
13,290
-22.6%
0.00%
Q2 2023$94,241
-31.6%
17,166
-47.7%
0.00%
Q1 2023$137,874
+18.0%
32,827
-22.2%
0.00%
Q4 2022$116,822
+199.5%
42,174
+176.8%
0.00%
Q3 2022$39,000
-92.7%
15,235
-89.8%
0.00%
Q2 2022$537,000
+329.6%
148,943
+640.9%
0.00%
Q1 2022$125,000
-23.8%
20,104
-14.6%
0.00%
Q3 2021$164,000
+131.0%
23,545
+80.7%
0.00%
Q1 2021$71,000
-48.9%
13,033
-71.0%
0.00%
Q2 2020$139,000
+17.8%
44,884
-23.5%
0.00%
Q2 2019$118,000
-62.4%
58,670
-1.9%
0.00%
Q3 2018$314,000
+390.6%
59,833
+367.1%
0.00%
Q1 2018$64,000
-21.0%
12,809
-52.0%
0.00%
Q1 2016$81,000
+42.1%
26,678
+77.3%
0.00%
Q3 2015$57,000
-38.7%
15,051
-6.9%
0.00%
Q2 2015$93,000
-80.7%
16,162
-84.7%
0.00%
-100.0%
Q2 2014$482,000
+619.4%
105,862
+653.6%
0.00%
Q1 2014$67,000
+219.0%
14,047
+216.0%
0.00%
Q4 2013$21,000
-90.8%
4,445
-89.8%
0.00%
Q3 2013$229,000
+25.1%
43,600
+13.1%
0.00%
Q2 2013$183,00038,5490.00%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q1 2022
NameSharesValueWeighting ↓
Harvey Partners, LLC 1,020,036$7,120,0005.32%
Portolan Capital Management 2,358,010$16,459,0001.20%
Acuitas Investments, LLC 375,836$2,623,0001.14%
Parkman Healthcare Partners LLC 475,367$3,318,0000.84%
Adirondack Research & Management Inc. 90,020$628,0000.76%
Archon Capital Management LLC 736,236$5,139,0000.73%
BARD ASSOCIATES INC 294,697$2,057,0000.70%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 1,621,775$11,320,0000.65%
GLOBEFLEX CAPITAL L P 268,466$1,874,0000.41%
Monarch Partners Asset Management LLC 330,083$2,304,0000.34%
View complete list of HARVARD BIOSCIENCE INC shareholders